Title: Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes.
Journal: Chemico-biological interactions 20100127
Title: Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090501
Title: Chemoprevention of rat prostate carcinogenesis by dietary 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone.
Journal: Carcinogenesis 20070201
Title: Dehydroepiandrosterone inhibits the progression phase of mammary carcinogenesis by inducing cellular senescence via a p16-dependent but p53-independent mechanism.
Journal: Breast cancer research : BCR 20050101
Title: Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.
Journal: European journal of cancer (Oxford, England : 1990) 20040601
Title: A synthetic androstene analogue inhibits collagen-induced arthritis in the mouse.
Journal: Clinical immunology (Orlando, Fla.) 20040201
Title: Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
Journal: International journal of pharmaceutics 20031002
Title: A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model.
Journal: Journal of neurotrauma 20030501
Title: A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.
Journal: Journal of neuroimmunology 20020901
Title: Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Journal: Cancer research 20020701
Title: Inhibition of adjuvant-induced arthritis by 16 alpha-fluoro-5-androsten-17-one.
Journal: Military medicine 20020201
Title: Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and inflammation by the dehydroepiandrosterone analog 16alpha-fluoro-5-androsten-17-one and its reversal by NADPH liposomes.
Journal: Cancer letters 20010710
